Opinion/decision on a Paediatric investigation plan (PIP): Dovato, lamivudine,dolutegravir, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0121/2023

EMEA-001855-PIP01-15-M04

Opinion/decision on a Paediatric investigation plan (PIP): Byfavo, remimazolam besilate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Anaesthesiology, PIP number: P/0110/2023

Opinion/decision on a Paediatric investigation plan (PIP): Kyprolis, carfilzomib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology;Oncology, PIP number: P/0107/2023

European Union example instances - E2B(R3) testing files

Test cases (1a-10) RTFs

EudraVigilance - EVWEB user manual

EudraVigilance registration manual

Herbal medicinal product: Foeniculi amari fructus aetheroleumArray, F: Assessment finalised

Clinical Trials Information System (CTIS): Walk-in clinic - July 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 July 2024, 16:00 (CEST) to 10 July 2024, 17:00 (CEST)